Avexxin is a pharmaceutical company focused on developing and commercializing novel small molecule therapeutics for patients with chronic inflammatory conditions. Avexxin's advanced understanding of the biology of the inflammator
y process has resulted in a novel therapeutic approach for the treatment of psoriasis and other inflammatory disorders.
Avexxin pipeline status
